convirox 150 mg cápsulas
oxialfarm cia ltda [ec] ecuador - atazanavir sulfato 0.170 g (equivalente a 150 mg de atazanavir base) - capsula - cada cápsula contiene: atazanavir sulfato 0.170 g (equivalente a 150 mg de atazanavir base)
anzavir 300 mg capsulas
pediatrics pharma, c.a. - atazanavir - capsulas - 300 mg
reyataz 150 mg capsulas
bristol-myers de venezuela, s.c.a. - atazanavir sulfato - c - 150 mg
reyataz 200 mg capsulas
bristol-myers de venezuela, s.c.a. - atazanavir sulfato - c - 200 mg
reyduo comprimidos recubiertos
bristol - myers squibb de chile - atazanavir; cobicistat - sin formulas
reyataz cápsulas 100 mg
bristol - myers squibb de chile - atazanavir - sin formulas
reyataz 100 mg capsulas
bristol-myers de venezuela, s.c.a. - atazanavir sulfato - capsula - 100 mg
atazanavir/ritonavir mylan 300 mg/ 100 mg tabletas recubiertas
mylan laboratories limited - tabletas recubiertas - 300 mg/ 100 mg
triumeq
viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - infecciones por vih - antivirales para uso sistémico - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.
tybost
gilead sciences ireland uc - cobicistat - infecciones por vih - antivirales para uso sistémico - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.